Public Profile

Padagis US LLC

Padagis US LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and specialty medications. Founded in 2015, the company has rapidly established itself as a trusted provider, focusing on areas such as injectables and complex formulations. With a commitment to innovation, Padagis offers a diverse portfolio of products that stand out for their quality and efficacy. The company’s state-of-the-art facilities and rigorous quality control processes ensure that its offerings meet the highest industry standards. Notably, Padagis has achieved significant milestones in expanding its market presence, positioning itself as a reliable partner for healthcare providers and patients alike.

DitchCarbon Score

How does Padagis US LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Padagis US LLC's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Padagis US LLC's reported carbon emissions

Padagis US LLC, headquartered in the United States, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate an opportunity for the company to enhance transparency and engage in industry-standard climate commitments. As the global focus on sustainability intensifies, Padagis US LLC may consider establishing measurable targets and reporting frameworks to align with best practices in emissions reduction and climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Padagis US LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Padagis US LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Padagis US LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

DMK Pharmaceuticals Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Alvogen, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Apotex

CA
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Mallinckrodt plc

IE
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Emergent BioSolutions

US
Research and development services (73)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers